Overview

Investigating the Effect of Topical Imiquimod on Sebaceous Hyperplasia

Status:
RECRUITING
Trial end date:
2027-09-11
Target enrollment:
Participant gender:
Summary
This study is being completed to determine if 8 weeks of treatment with imiquimod can shrink sebaceous hyperplasia.
Phase:
PHASE4
Details
Lead Sponsor:
University of Michigan
Treatments:
Imiquimod